Charlesbank Capital Partners is pleased to announce the election of J. Ryan Carroll as Managing Director of the firm. Previously a Vice President, Mr. Carroll joined Charlesbank in 2000 from LEK Consulting, a global strategy consulting firm.
Including Mr. Carroll, Charlesbank’s investment staff comprises 20 professionals from a variety of backgrounds. The senior team has worked together, on average, for 16 years.
Mr. Carroll graduated cum laude from Harvard University with a BA in economics. He currently serves on the boards of DEI Holdings, OnCore Manufacturing, Peacock Engineering and Zenith Products, and is also involved with the firm’s investment in Zayo. In addition, he serves on the Exceptional Care Without Exception Trust board at Boston Medical Center. He is a resident of Boston.
Of the appointment, Michael Eisenson, Managing Director and CEO of Charlesbank, said, “Ryan has made an extraordinary contribution to Charlesbank in the past 12 years, actively helping to identify new investment opportunities and to guide our existing portfolio. I have great confidence in his abilities and look forward to having him become even more deeply engaged in the management of the firm.”
ABOUT CHARLESBANK CAPITAL PARTNERS
Charlesbank Capital Partners is a middle-market private equity investment firm managing more than $2 billion of capital. Charlesbank focuses on management-led buyouts and growth capital financings, typically investing $50 million to $150 million per transaction in companies with enterprise values of $100 million to $750 million. The firm seeks to partner with strong management teams to build companies with sustainable competitive advantages and excellent prospects for growth. For more information, www.charlesbank.com.